Dan Primack & Albert Bourla , Axios Re:Cap

Pfizer CEO Albert Bourla on the blockbuster COVID-19 vaccine news

09 Nov 2020 • 14 min • EN
14 min
00:00
14:41
No file found

Pfizer on Monday announced that its COVID-19 vaccine has proven effective in preventing infection in over 90% of Phase 3 clinical trial patients, and added that it could have 50 million doses available by year-end. Dan talks to Pfizer CEO Albert Bourla about data, distribution, politics, and how he reacted upon receiving the news. Learn more about your ad choices. Visit megaphone.fm/adchoices

From "Axios Re:Cap"

Listen on your iPhone

Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?

App Store Logo
application screenshot

Popular categories